Group One Trading
TXMD icon

Group One Trading’s TherapeuticsMD TXMD Stock Holding History

Group One Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,000
Closed -$4.24K – 9194
2025
Q3 		$4.24K Sell
4,000
-200
-5% -$224 ﹤0.01% 7623
2025
Q2 		$4.87K Buy
+4,200
New +$5.09K ﹤0.01% 7091
2025
Q1 		– Sell
-9,800
Closed -$8.43K – 8396
2024
Q4 		$8.43K Hold
9,800
– – ﹤0.01% 6186
2024
Q3 		$16.3K Hold
9,800
– – ﹤0.01% 5345
2024
Q2 		$15.8K Hold
9,800
– – ﹤0.01% 5378
2024
Q1 		$22.4K Hold
9,800
– – ﹤0.01% 5335
2023
Q4 		$22.1K Sell
9,800
-37,600
-79% -$90.7K ﹤0.01% 5672
2023
Q3 		$143K Sell
47,400
-55,100
-54% -$209K ﹤0.01% 4108
2023
Q2 		$422K Buy
102,500
+38,200
+59% +$150K ﹤0.01% 3188
2023
Q1 		$241K Sell
64,300
-47,000
-42% -$226K ﹤0.01% 3493
2022
Q4 		$622K Sell
111,300
-35,700
-24% -$210K ﹤0.01% 2841
2022
Q3 		$976K Sell
147,000
-50,300
-25% -$407K ﹤0.01% 2607
2022
Q2 		$1.96M Buy
197,300
+194,392
+6,685% +$1.86M ﹤0.01% 2082
2022
Q1 		$55K Sell
2,908
-3,870
-57% -$60.9K ﹤0.01% 6022
2021
Q4 		$120K Buy
6,778
+362
+6% +$10.8K ﹤0.01% 5561
2021
Q3 		$238K Sell
6,416
-7,426
-54% -$330K ﹤0.01% 4990
2021
Q2 		$824K Sell
13,842
-3,882
-22% -$235K ﹤0.01% 3629
2021
Q1 		$1.19M Buy
17,724
+11,828
+201% +$926K ﹤0.01% 3021
2020
Q4 		$357K Buy
5,896
+550
+10% +$37.5K ﹤0.01% 3574
2020
Q3 		$422K Buy
5,346
+816
+18% +$65K ﹤0.01% 2992
2020
Q2 		$283K Buy
4,530
+1,412
+45% +$82.2K ﹤0.01% 3100
2020
Q1 		$165K Sell
3,118
-5,580
-64% -$553K ﹤0.01% 2907
2019
Q4 		$1.05M Buy
8,698
+1,104
+15% +$159K 0.01% 1834
2019
Q3 		$1.38M Buy
7,594
+3,372
+80% +$475K 0.01% 1492
2019
Q2 		$549K Buy
4,222
+1,276
+43% +$229K 0.01% 2052
2019
Q1 		$717K Sell
2,946
-530
-15% -$140K 0.01% 1666
2018
Q4 		$662K Buy
3,476
+1,362
+64% +$332K 0.01% 1808
2018
Q3 		$693K Sell
2,114
-1,486
-41% -$455K 0.01% 1989
2018
Q2 		$1.12M Buy
3,600
+1,544
+75% +$472K 0.01% 1623
2018
Q1 		$501K Sell
2,056
-1,494
-42% -$419K 0.01% 2067
2017
Q4 		$1.07M Sell
3,550
-1,074
-23% -$299K 0.01% 1644
2017
Q3 		$1.22M Sell
4,624
-2,342
-34% -$677K 0.01% 1410
2017
Q2 		$1.84M Buy
6,966
+2,232
+47% +$559K 0.02% 1011
2017
Q1 		$1.7M Buy
4,734
+2,312
+95% +$715K 0.02% 971
2016
Q4 		$699K Buy
2,422
+254
+12% +$78.7K 0.01% 1556
2016
Q3 		$738K Sell
2,168
-2,094
-49% -$765K 0.01% 1506
2016
Q2 		$1.81M Buy
4,262
+576
+16% +$237K 0.02% 873
2016
Q1 		$1.18M Sell
3,686
-2,068
-36% -$705K 0.02% 1066
2015
Q4 		$2.98M Buy
5,754
+1,518
+36% +$560K 0.04% 624
2015
Q3 		$1.24M Buy
4,236
+1,990
+89% +$707K 0.02% 1091
2015
Q2 		$883K Sell
2,246
-1,768
-44% -$624K 0.01% 1309
2015
Q1 		$1.21M Buy
4,014
+3,752
+1,432% +$916K 0.02% 929
2014
Q4 		$58K Sell
262
-686
-72% -$141K ﹤0.01% 3271
2014
Q3 		$220K Buy
948
+644
+212% +$162K ﹤0.01% 2298
2014
Q2 		$67K Buy
304
+174
+134% +$38.7K ﹤0.01% 3339
2014
Q1 		$41K Buy
+130
New +$41.4K ﹤0.01% 3767

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TXMD Position: Q1 2026 in Review

Group One Trading reduced its TherapeuticsMD (TXMD) stake by 100% in Q1 2026, selling an estimated $3.58K and leaving 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #7479.

Group One Trading first reported a position in TXMD in Q2 2014 and has held it in 33 quarters since. The position peaked at $1.48M in Q3 2018. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Group One Trading held 2 shares of TherapeuticsMD worth $4 as of Q1 2026.
  • Group One Trading sold 1,594 TherapeuticsMD shares in Q1 2026, an estimated $3.58K.
  • TherapeuticsMD made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7479 holding.
  • Group One Trading first reported a position in TherapeuticsMD in Q2 2014 and has held it in 33 quarters since.
  • Group One Trading's TherapeuticsMD position peaked at $1.48M in Q3 2018.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.